Welcome to our dedicated page for Privia Health Group news (Ticker: PRVA), a resource for investors and traders seeking the latest updates and insights on Privia Health Group stock.
Privia Health Group, Inc. (Nasdaq: PRVA) is a technology-driven physician enablement company that regularly issues detailed updates on its operations, value-based care performance, and network expansion. Its news flow often includes quarterly financial results, guidance updates, and announcements related to Accountable Care Organizations (ACOs) and partnerships with independent physician groups.
Investors following PRVA news can expect recurring earnings releases that highlight metrics such as total revenue, gross profit, operating income, net income, Adjusted EBITDA, Implemented Providers, Value-Based Care Attributed Lives, Practice Collections, Care Margin, and Platform Contribution. The company frequently discusses its performance in the Medicare Shared Savings Program (MSSP) and other value-based arrangements, including aggregate shared savings achieved by its Privia Quality Network ACOs.
Privia Health also uses news releases to announce strategic transactions and geographic expansion. Recent examples include a definitive agreement to acquire an ACO business from Evolent Health, Inc., which serves more than 120,000 attributed lives, and entry into the Arizona market through a partnership with Integrated Medical Services, Inc., a large independent multi-specialty practice. These updates provide insight into how the company is growing its presence across 15 states and the District of Columbia and increasing the number of attributed lives in value-based care arrangements.
In addition, PRVA news may cover governance and board changes, such as the appointment of new directors with technology and cybersecurity expertise. For readers interested in physician enablement, value-based care, and healthcare technology, the Privia Health news feed offers a view into how the company reports its progress, adjusts its full-year guidance, and describes the performance of its physician networks and ACOs over time.
Privia Health Group, Inc. (Nasdaq: PRVA) announced a public offering of 6,000,000 shares of common stock by certain selling stockholders, with a 30-day option for underwriters to purchase an additional 900,000 shares. The company will not receive any proceeds from this offering, as costs will be borne by the selling stockholders. Goldman Sachs & Co. LLC and J.P. Morgan are leading the offering. A registration statement has been filed but is not yet effective, and the offering is subject to numerous conditions outside Privia's control.
Privia Health Group, Inc. (PRVA) announced robust third-quarter results with total revenue reaching $251.5 million, a 21.4% increase year-over-year. However, the company reported a net loss of $9.1 million, or $0.09 per share, compared to a profit of $16.7 million in the same period last year. Practice collections rose to $401.5 million, and adjusted EBITDA grew by 51.9% to $13.9 million. The firm entered the California and West Texas markets, raising its full-year 2021 guidance across multiple metrics, signaling strong growth potential ahead.
Privia Health Group, Inc. (Nasdaq: PRVA), a national physician enablement company, announced its participation in three key investor conferences. The events are scheduled for November 10 at the Credit Suisse Healthcare Conference, November 18 at the Canaccord Genuity Digital Health & Services Forum, and December 1 at the Piper Sandler Healthcare Conference. Webcasts and slide presentations will be accessible via the company's investor relations website. Privia Health focuses on enhancing physician practices and patient experiences through advanced technology.
Privia Health Group, Inc. (PRVA) is expanding its national provider network by collaborating with over 430 new providers in California and Texas. This includes partnerships with BASS Medical Group in California and Abilene Diagnostic Clinic in West Texas. These ventures aim to enhance patient care and support healthcare providers in their transition to value-based care. The company plans to update its full-year 2021 guidance following its third-quarter financial results on November 8, reflecting the anticipated impact of these expansions.
Privia Health Group (Nasdaq: PRVA) is set to announce its third-quarter financial results for the period ending September 30, 2021, before market open on November 8, 2021. The financial press release will be available at ir.priviahealth.com by 7:00 am ET. Management will also hold a conference call at 8:00 am ET to discuss the results and future outlook. Interested parties can participate via a webcast or by dialing 855-940-5315.
BOSTON--(BUSINESS WIRE)--Kyruus announced that Privia Health is now using the Kyruus ProviderMatch platform to enhance patient access and streamline online appointment bookings. Privia Health serves approximately 2,700 providers and 3 million patients, aiming to improve consumer self-service and reduce administrative burdens. The integration facilitates a seamless search experience, allowing patients to find providers based on specific needs. With online scheduling activated for nearly 1,200 providers, Privia is poised for further growth in digital offerings.
Biote Medical has announced the election of Dr. Mark Cone and Dana Jacoby to its Board of Directors, strengthening its leadership team with over 60 years of combined experience in healthcare and business management. Dr. Cone is the Market President of Privia Health in South Texas, while Jacoby has led nearly $1 billion in healthcare mergers and transactions. Their appointments aim to enhance Biote's growth and address hormone deficiencies affecting over 200 million Americans.
Privia Health Group (Nasdaq: PRVA) reported impressive results for 2020, achieving $86.5 million in shared savings through its Accountable Care Organizations (ACOs) via the Medicare Shared Savings Program (MSSP). The Privia Quality Network served over 121,000 Medicare beneficiaries, demonstrating a commitment to quality care while lowering costs. Key metrics showed that Privia's expenditures were 15% lower than the median MSSP ACO and emergency room utilization was 22% lower. Since 2014, total shared savings exceed $519 million.
Privia Health Group, Inc. (Nasdaq: PRVA) reported strong revenue growth in Q2 2021, with total revenue climbing to $225.8 million, a 23.2% increase year-over-year. However, the company faced significant operating and net losses of $193.2 million and $172.5 million, respectively, mainly due to $202.6 million in non-cash stock compensation expense related to its IPO. Excluding these, non-GAAP adjusted net income increased 69.0% to $10.4 million. The company expects continued growth with increased provider partnerships and attributed lives, revising its full-year guidance upwards.
Privia Health Group (Nasdaq: PRVA) has announced its financial results release for the second quarter ended June 30, 2021, scheduled for August 9, 2021, before market open. The financial results will be available at 7:00 am ET on the company's Investor Relations website. Additionally, a conference call will follow at 8:00 am ET the same day to discuss the results and future outlook. Interested parties can access the call via webcast or by dialing 855-940-5315.
FAQ
What is the current stock price of Privia Health Group (PRVA)?
What is the market cap of Privia Health Group (PRVA)?
